Investigating Carvedilol’s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists

Repurposing existing drugs appears to be a potential solution for addressing the challenges in the treatment of non-small cell lung cancer (NSCLC). β-adrenoceptor antagonist drugs (β-blockers) have tumor-inhibiting effects, making them promising candidates for potential NSCLC treatment. This study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikhmais, Balqis A., Hammad, Alaa M., Abusara, Osama H., Hamadneh, Lama, Abumansour, Hamza, Abdallah, Qasem M., Ibrahim, Ali I. M., Elsalem, Lina, Awad, Mariam, Alshehada, Rahaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605277/
https://www.ncbi.nlm.nih.gov/pubmed/37886948
http://dx.doi.org/10.3390/cimb45100505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605277/
https://www.ncbi.nlm.nih.gov/pubmed/37886948
http://dx.doi.org/10.3390/cimb45100505

Ejemplares similares